Products with Hepatoprotective Bioactivity
Explore BioCrick products associated with Hepatoprotective biological activity, including catalog numbers, product names and available bioactivity information.
Hepatoprotective Bioactivity Products
| Cat. No. | Product Name |
|---|---|
| BCN1285 | Phytin |
| 1. Phytin and magnesium citrate have hypocalciuric effect , they can reduce urinary calcium excretion in rats fed on high-calcium diets. 2. A six-day treatment with phytin can restore the normal level of the liver monooxygenase system components and MMW peptides, also can reduce the level of lactic acid (LA) and increased that of pyruvic acid (PA) in liver tissues, which lead to a sharp drop in the LA/MA ratio indicative of a decrease in the extent of hypoxia. 3. Individually phytin, EDTA and copper (Cu2+) have inhibitory effect on growth of Gram positive as well as Gram negative bacteria, phytin preferentially protects only Gram negative bacteria from Cu 2+ ion toxicity,phytin also has chelating ability. | |
| BCN1418 | Soyasaponin II |
| 1. Soyasaponin II has antiviral effects, it can inhibit the replication of human cytomegalovirus, influenza virus, and human immunodeficiency virus type 1. 2. Soyasaponins II can inhibit the conversion of fibrinogen to fibrin, it also can promote activation of the fibrinolytic system in a plasminogen-containing fibrin plate. 3. Soyasaponin II has hepatoprotective actions towards immunologically induced liver injury on primary cultured rat hepatocytes. 4. Soyasaponins are a potential antitumor compound and the apoptosis induced by soyasaponins is a key antitumor mechanism. | |
| BCN1433 | Soyasapogenol A |
| 1. Soyasapogenol A and soyasapogenol B concentrated extracts show a greater ability to inhibit proliferation of cultured Hep-G2 when compared to a total soyasaponin extract that did not contain any soyasapogenols. 2. Soyasapogenol A directly prevents apoptosis of hepatocytes, and secondly, inhibits the elevation of plasma TNF-α, which consequently resulted in the prevention of liver damage in the concanavalin A-induced hepatitis model. 3. Soyasapogenol A shows estrogenic activities. | |
| BCN1627 | Soyasaponin IV |
| 1. Soyasaponin IV has hepatoprotective activity. 2. Soyasaponin IV has antimutagenic activity in mammalian cells. | |
| BCN1655 | 6-O-(3'',4''-Dimethoxycinnamoyl)catalpol |
| 1. 6-O-(3'',4''-Dimethoxycinnamoyl)catalpol has anti-hepatotoxic activity. | |


